Project Number 5P01AG014449-24 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Project 4 (Pitts)-Cholinergic and amyloid alteration in mild cognitive impairment Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category F. Research Resources 2. Other Types of Cores or Centers Researcher and Organization Principal Investigator IKONOMOVIC, MILOS D Principal Investigator First Name IKONOMOVIC Principal Investigator Last Name MILOS D Awardee Organization ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER Awardee State Arizona Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-297: NIA Program Project Applications (P01 Clinical Trial Optional) FY Overall Cost $376,223 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official OPANASHUK, LISA A. Related Resources Repository [AlzPED] Intravenous immunoglobulin reduces tau pathology and preserves neuroplastic gene expression in the 3xTg mouse model of Alzheimer's disease
